Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      The next person to shop your store may not be a person at all

      AI shopping agents are rewriting the rules of online retail across North America

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Cohere's Aidan Gomez bets the house on 'sovereign AI' with Aleph Alpha merger valuing the group at $20bn

      Cohere CEO Aidan Gomez on stage discussing the Toronto AI lab's strategy

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Moonvalley's Naeem Talukdar is selling Hollywood the one thing rival AI video tools cannot: legal cover

      Moonvalley's Marey AI video model produces Hollywood-grade footage trained on licensed data

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Tuesday 11 June 2024 8:42 am

Oxford Instruments shares jump as company to revamp ‘overly complex’ business structure

By: Bethany Wales

Add as a preferred source on Google
British microscope maker Oxford Instruments said it will change its "overly complex" business structure
British microscope maker Oxford Instruments said it will change its "overly complex" business structure

British microscope maker Oxford Instruments said it would change its “overly complex” business structure after its profit fell, despite revenue growth.

Shares in the company jumped eight per cent in early deals after the announcement.

The London-listed firm reported revenue of £470.4m in the 12 months ending March 31, 2024, a nine per cent increase on the previous period due to increased demand for its analysis tools.

However, the firm’s pre-tax profit fell from £73.5m to £71.3m, which CEO Richard Tyson said was due to a decision to stop trading in some parts of China.

He added: “We have rebalanced our positions in regional markets in the face of geopolitical shifts, focusing our resources on non-sensitive areas in China, and successfully growing revenue and orders in Europe and elsewhere in Asia.

“We have continued to make organic investments to support our future growth, with our state-of-the-art compound semiconductor facility now operational.

“Underlying order intake has remained robust, with a positive book to bill even though we had stronger growth in the second half, and the orderbook gives us good visibility into the year ahead.”

Read more

Babcock shares shrug off profit drop after £140m hit

Babcock is a member of the FTSE 100.

In an effort to increase its profit margins Oxford Instruments will split its operations into two new divisions – Imaging and Analysis and Advanced Technologies.

Tyson said the move would allow the business to take a more targeted approach to running each section and simplify operations.

The company expects revenue to be split 70/30 between the two divisions, with its Imaging and Analysis products likely to see the highest sales.

The company also announced a deal to buy anoindentation instrument developer Femtotools for up to 24m swiss Francs (£27m)

In the report published alongside its half year results, Oxford Instruments said: “With significant overlap between business units and markets, the structure of Oxford Instruments had become overly complex over a number of years, making it confusing for stakeholders to understand and leading to duplication of processes internally.

“Consolidating our eight business units and six previous end markets into just two divisions and three core markets, supported by a simplified customer-facing regional structure, will drive efficiencies and operational gearing, and provide greater transparency of Oxford Instruments as an investment proposition.”

Read more

ITV banks on World Cup boost as Sky talks rumble on

Studios revenue rose three per cent to £893m, driven by an 11 per cent jump in external sales to streaming platforms.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

People & Organisations

  • China
  • London
  • London Stock Exchange
  • Oxford Instuments

Related Topics

  • china
  • Oxford Instruments

Trending Articles

  • London Tech Week sums up everything wrong with UK tech

  • Inflation expectations at record high in interest rates signal

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

  • UK economy falters as deeper damage to growth to come

  • New Gluten-Free Bread Binder Simplifies the Recipe — and Boosts Bread Quality

More from CityAM

  • ZayZoon, the Calgary fintech born on a fishing boat, posts 1,487% growth as earned wage access goes mainstream

    ZayZoon co-founder Tate Hackert built the Calgary fintech around earned wage access
  • Botpress raises $25m as Quebec's Sylvain Perron pitches his startup as the 'infrastructure layer' for AI agents

    Botpress product UI: the Quebec startup pitches itself as the infrastructure layer for enterprise AI agents
  • FluidAI wins US FDA clearance for its surgical monitor as Waterloo's Youssef Helwa targets 100,000 operations

    FluidAI's Origin surgical monitor wins FDA clearance for use in US hospitals
  • Pets at Home hails ‘better momentum’ despite profit slip

    Retail
    Pets at home enjoying playtime in a cozy living room setting, featuring a content cat lounging and a playful dog with a toy.
  • ‘Inflection point’: Challenger banks loan growth halved in 2025

    Banking
    Getty Images logo on display, symbolizing media industry influence and visual content distribution in digital news platforms.
  • British American Tobacco shares slide as cigarette volumes decline

    Business
    British American Tobacco headquarters with falling stock prices graph, reflecting decline in cigarette volumes and share p...
  • Wizz Air ‘resilient’ after route cancellations wipe out profit

    Transport & Infrastructure
    Wizz Air reported a hefty drop in annual profit as it grapples with long-running supply chain issues and conflict Ukraine and the Middle East.
  • Tate & Lyle admits ‘disappointing year’ as US buyer circles

    Retail
    Tate & Lyle headquarters exterior showcasing modern architecture and company signage on a bustling city street
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited